Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03715478 |
| Title | Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Myeloma Canada Research Network |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cross Cancer Institute | Edmonton | Alberta | Canada | Details | ||
| Vancouver General Hospital | Vancouver | British Columbia | Canada | Details | ||
| CancerCare Manitoba | Winnipeg | Manitoba | Canada | Details | ||
| QEII Health Sciences Centre | Halifax | Nova Scotia | Canada | Details | ||
| Juravinski Cancer Centre | Hamilton | Ontario | Canada | Details | ||
| London Health Sciences Centre | London | Ontario | Canada | Details | ||
| The Ottawa Hospital | Ottawa | Ontario | Canada | Details | ||
| Princess Margaret Cancer Centre | Toronto | Ontario | Canada | Details | ||
| Allan Blair Cancer Centre | Regina | Saskatchewan | Canada | Details |